Biocon — Fact Sheet (June 2013)

3 slides from Biocon's fact sheet, June 2013

Slide 1: Biocon Group Fact Sheet June 2013
BIOCON GROUP FACT SHEET June - 2013 Q1 FY 2014 vs. Q1FY 2013
Slide 2: Biocon Limited (Consolidated) Unaudited Balance Sheet
BIOCON LIMITED (CONSOLIDATED) UNAUDITED BALANCE SHEET (Rs. Crores) June 30, 2013 March 31, 2013 EQUITY AND LIABILITIES Shareholder's Funds (a) Share capital 100 100 (b)Reserves and surplus 2,714 2,595 2,814 2,695 Minority interest 68 65 Non-current liabilities (a) Long-term borrowings 302 164 (b)Def
Slide 3: Biocon Limited (Consolidated) Unaudited Profit & Loss Statement
BIOCON LIMITED (CONSOLIDATED) UNAUDITED PROFIT & LOSS STATEMENT (Rs. Crores) Q1 Q1 Q4 Particulars FY 14 FY 13 Variance FY 13 Variance INCOME Biopharmaceuticals * 439 363 21% 379 16% Branded formulations - India 101 86 17% 85 19% Total Biopharmaceuticals 540 449 20% 464 16% Contract research 155 123